Amy Non

Dr. Amy Non

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Biological Psychology
Verified
Journal Article
Closed access
MRMarissa Rewak
Marissa Rewak
SBStephen L. Buka
Stephen L. Buka
JPJennifer Prescott
Jennifer Prescott
IVImmaculata De Vivo
Immaculata De Vivo
ELEric B. Loucks
Eric B. Loucks
LKLaura D. Kubzansky
Laura D. Kubzansky

19 May 2022 in Human Genomics
Verified
Journal Article
Open access
PDF file
JCJessica P. Cerdeña
Jessica P. Cerdeña
VGVanessa Grubbs
Vanessa Grubbs
ANAmy Non
Amy Non
Background: Recent studies have reignited the tinderbox of debate surrounding the use of race and ancestry in medicine. These controversial studies have argued for a strong correlation between genetic ancestry and race, justifying continued use of genetic ancestry measures in studies of disease. These studies contend that increased use of continental ancestry estimates can inform clinical risk assessments and management. Further, recent studies of racial corrections used in clinical algorithms, such as those used to estimate 'normal' lung function, also advocate for use of genetic ancestry in place of race for refining risk algorithms. Main body: These positions are misleading, harmful, and reflect superficial interpretations of population genetics. In this Perspective, we argue that continental genetic ancestry, often proxied by race, serves as a poor indicator of disease risk, and reinforces racialized inequities. Conclusion: Instead, we endorse that racial disparities in disease should be investigated by rigorous measures of structural racism alongside careful measures of genetic factors in relevant disease pathways, rather than relying on genetic ancestry or race as a crude proxy for disease-causing alleles.

2 November 2015 in American Anthropologist
Verified
Journal Article
Closed access
PDF file
ZTZaneta M. Thayer
Zaneta M. Thayer
ANAmy Non
Amy Non

13 January 2016 in Annals of Human Biology
Verified
Journal Article
Closed access
PDF file
ANAmy Non
Amy Non
JRJorge Carlos Román
Jorge Carlos Román
CGChristopher L. Gross
Christopher L. Gross
SGStephen E. Gilman
Stephen E. Gilman
ELEric B. Loucks
Eric B. Loucks
LKLaura D. Kubzansky
Laura D. Kubzansky
Background: Individual health behaviours are considered important risk factors for cardiometabolic diseases. These behaviours may be socially patterned by early exposure to social disadvantage, but few studies have prospectively tested this hypothesis empirically. Aim: This study investigated whether childhood social disadvantage was associated with likelihood of engaging in less healthy behaviours 40 years later. Subjects and methods: Prospective data were analysed from the New England Family Study, a 2005–2007 adult follow-up of a cohort initiated in 1959–1966 (n = 565). Childhood social environment (age 7 years) was assessed using a cumulative index of socioeconomic and family stability factors. Logistic regression models evaluated associations between social disadvantage and each health-related behaviour and obesity in adulthood. Results: Relative to low disadvantage, higher disadvantage was associated with 3.6-fold greater odds of smoking (95% CI = 1.9–7.0), 4.8-fold greater odds (in women only) of excess alcohol consumption (95% CI = 1.6–14.2) and 2.7-fold greater odds of obesity (95% CI = 1.3–5.5), but was not associated with unhealthy diet or physical inactivity. Conclusion: These findings suggest childhood social disadvantage may contribute to adult cardiometabolic disease by predisposing children to adopt certain unhealthy behaviours. If replicated, such findings may support intervention strategies that target social environmental factors and behavioural pathways that are established early in life.

9 January 2017 in BMC Genomics
Verified
Journal Article
Open access
PDF file
KOKathryn Tully Oelsner
Kathryn Tully Oelsner
Yan GuoYan Guo
Yan Guo
STSophie Bao-Chieu To
Sophie Bao-Chieu To
ANAmy Non
Amy Non
SBShari L. Barkin
Shari L. Barkin
The study of epigenetic processes and mechanisms present a dynamic approach to assess complex individual variation in obesity susceptibility. However, few studies have examined epigenetic patterns in preschool-age children at-risk for obesity despite the relevance of this developmental stage to trajectories of weight gain. We hypothesized that salivary DNA methylation patterns of key obesogenic genes in Hispanic children would 1) correlate with maternal BMI and 2) allow for identification of pathways associated with children at-risk for obesity. Genome-wide DNA methylation was conducted on 92 saliva samples collected from Hispanic preschool children using the Infinium Illumina HumanMethylation 450 K BeadChip (Illumina, San Diego, CA, USA), which interrogates >484,000 CpG sites associated with ~24,000 genes. The analysis was limited to 936 genes that have been associated with obesity in a prior GWAS Study. Child DNA methylation at 17 CpG sites was found to be significantly associated with maternal BMI, with increased methylation at 12 CpG sites and decreased methylation at 5 CpG sites. Pathway analysis revealed methylation at these sites related to homocysteine and methionine degradation as well as cysteine biosynthesis and circadian rhythm. Furthermore, eight of the 17 CpG sites reside in genes (FSTL1, SORCS2, NRF1, DLC1, PPARGC1B, CHN2, NXPH1) that have prior known associations with obesity, diabetes, and the insulin pathway. Our study confirms that saliva is a practical human tissue to obtain in community settings and in pediatric populations. These salivary findings indicate potential epigenetic differences in Hispanic preschool children at risk for pediatric obesity. Identifying early biomarkers and understanding pathways that are epigenetically regulated during this critical stage of child development may present an opportunity for prevention or early intervention for addressing childhood obesity. The clinical trial protocol is available at ClinicalTrials.gov ( NCT01316653 ). Registered 3 March 2011

8 December 2022 in The Lancet
Verified
Journal Article
Closed access
JCJessica P Cerdeña
Jessica P Cerdeña
VGVanessa Grubbs
Vanessa Grubbs
ANAmy Non
Amy Non